Concepedia

Mark A. Preston

MA

Statistics

Publications

73

Citations

5.5K

H-Index

35

Active since

1994

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Dana-Farber Brigham Cancer Center

Massachusetts General Hospital

Mark A. Preston is an author at Brigham and Women's Hospital specializing in medicine, oncology, and urology.

ORCID

Publications per year

1994–2025

73

Publications

73

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 628 citations · Full text

, , +16

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology · 2021 · 372 citations · Full text

, , +17

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

Thomas W. Flaig, Philippe E. Spiess, Michael Abern et al. · Journal of the National Comprehensive Cancer Network · 2022 · 302 citations · Full text

, , +17

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Philippe E. Spiess, Neeraj Agarwal, Rick Bangs et al. · Journal of the National Comprehensive Cancer Network · 2017 · 280 citations · Full text

, , +17

Bladder Cancer, Version 3.2024

Thomas W. Flaig, Philippe E. Spiess, Michael Abern et al. · Journal of the National Comprehensive Cancer Network · 2024 · 236 citations · Full text

, , +12

1–5 of 73